153
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Accuracy Rate of Methylene Blue Injection in Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer Patients: A Prospective Observational Study

, , , , , & ORCID Icon show all
Pages 891-897 | Received 09 Sep 2023, Accepted 05 Dec 2023, Published online: 07 Dec 2023

References

  • Maaskant-Braat AJ, de Bruijn SZ, Woensdregt K, Pijpers H, Voogd AC, Nieuwenhuijzen GA. Lymphatic mapping after previous breast surgery. Breast. 2012;21(4):444–448. doi:10.1016/j.breast.2011.10.007
  • Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca a Cancer J Clinicians. 2021;71(3):209–249. doi:10.3322/caac.21660
  • Shim VC. How much is enough? The continuing debate on the axillary lymph node dissection in breast cancer. Perm J. 2007;11(2):77. doi:10.7812/TPP/06-085
  • Wong SL, Edwards MJ, Chao C, et al. The effect of prior breast biopsy method and concurrent definitive breast procedure on success and accuracy of sentinel lymph node biopsy. Ann Surg Oncol. 2002;9:272–277. doi:10.1007/BF02573065
  • Zahoor S, Haji A, Battoo A, Qurieshi M, Mir W, Shah M. Sentinel lymph node biopsy in breast cancer: a clinical review and update. J Breast Cancer. 2017;20(3):217–227. doi:10.4048/jbc.2017.20.3.217
  • Rahman M, Mohammed S. Breast cancer metastasis and the lymphatic system. Oncol Lett. 2015;10(3):1233–1239. doi:10.3892/ol.2015.3486
  • Weaver DL. Pathology evaluation of sentinel lymph nodes in breast cancer: protocol recommendations and rationale. Mod Pathol. 2010;23(2):S26–32. doi:10.1038/modpathol.2010.36
  • Li J, Chen X, Qi M, Li Y. Sentinel lymph node biopsy mapped with methylene blue dye alone in patients with breast cancer: a systematic review and meta-analysis. PLoS One. 2018;13(9):e0204364. doi:10.1371/journal.pone.0204364
  • East JM, Valentine CS, Kanchev E, Blake GO. Sentinel lymph node biopsy for breast cancer using methylene blue dye manifests a short learning curve among experienced surgeons: a prospective tabular cumulative sum (CUSUM) analysis. BMC Surg. 2009;9:1–8. doi:10.1186/1471-2482-9-2
  • Filippakis GM, Zografos G. Contraindications of sentinel lymph node biopsy: are there any really? World Journal of Surgical Oncology. 2007;5(1):1. doi:10.1186/1477-7819-5-10
  • Welch HG, Prorok PC, O’Malley AJ, Kramer BS. Breast-cancer tumor size, overdiagnosis, and mammography screening effectiveness. N Engl J Med. 2016;375(15):1438–1447. doi:10.1056/NEJMoa1600249
  • Mansel R, Webster D, Sweetland H. Breast anatomy and physiology. In: Hughes, Mansel & Webster’s Benign Disorders and Diseases of the Breast. 4th ed. New York: Elsevier Health Sciences; 2012:7–20.
  • Williams NS, Bullstrode CJK, O’Connell PR. Bailey & Love’s Short Practice of Surgery. Annals of The Royal College of Surgeons of England; 2010:178.
  • Alavifard R, Kadkhodayan S, Shandiz FH, Dabbagh VR, Sadeghi R. Is sentinel node mapping possible in surgically removed ectopic axillary breast cancer? A case report. Nucl Med Rev. 2016;19(B):29–30. doi:10.5603/NMR.2016.0036
  • Dogan NU, Dogan S, Favero G, Köhler C, Dursun P. The basics of sentinel lymph node biopsy: anatomical and pathophysiological considerations and clinical aspects. J Oncol. 2019;2019:1–10. doi:10.1155/2019/3415630
  • Özdemir A, Mayir B, Demirbakan K, Oygür N. Efficacy of methylene blue in sentinel lymph node biopsy for early breast cancer. Eur J Breast Health. 2014;10(2):88. doi:10.5152/tjbh.2014.1914
  • Bandyopadhyay S, Bluth MH, Ali-Fehmi R. Breast carcinoma: updates in molecular profiling 2018. Clinics Lab Med. 2018;38(2):401–420. doi:10.1016/j.cll.2018.02.006
  • Forghani MN, Memar B, Jangjoo A, et al. The effect of excisional biopsy on the accuracy of sentinel lymph node mapping in early stage breast cancer: comparison with core needle biopsy. Am Surg. 2010;76(11):1232–1235. doi:10.1177/00031348100760112
  • Cuschieri S. The STROBE guidelines. Saudi J Anaesth. 2019;13(Suppl 1):S31. doi:10.4103/sja.SJA_543_18
  • Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453–1457. doi:10.1016/S0140-6736(07)61602-X
  • Cardoso F, Kyriakides S, Ohno S, et al. Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2019;30(8):1194–1220. doi:10.1093/annonc/mdz173
  • Azhar Y, Dewayani BM, Lukman K. Methylene blue sentinel lymph node biopsy for breast cancer learning curve in the COVID-19 era: how many cases are enough? F1000Res. 2023;11:740. doi:10.12688/f1000research.122408.2
  • Levy PS, Lemeshow S. Sampling of Populations: Methods and Applications. John Wiley & Sons; 2013:21–27.
  • Lwanga SK, Lemeshow S; World Health Organization. Sample Size Determination in Health Studies: A Practical Manual. World Health Organization; 1991:7–9.
  • Fitzgibbons PL, Connolly J. Protocol for the Examination of Biopsy Specimens from Patients with Invasive Carcinoma of the Breast. College of American Pathologists (CAP); 2019:1–6.
  • Surabhi DM, Wilson JC, Singh M, Green L. Recognizing invasive breast carcinoma of no special type with medullary pattern. Radiol Case Rep. 2023;18(5):1788–1792. doi:10.1016/j.radcr.2023.01.052
  • Cserni G. Histological type and typing of breast carcinomas and the WHO classification changes over time. Pathologica. 2020;112(1):25. doi:10.32074/1591-951X-1-20
  • Winchester. DJ:. Evaluation and Surgical Management of Stage I and II Breast Cancer. In: ‘Breast Cancer Atlas of Clinical Oncology’. Chicago: American Cancer Society; 2000:146.
  • Garcia-Tejedor A, Ortega-Exposito C, Salinas S, et al. Axillary lymph node dissection versus radiotherapy in breast cancer with positive sentinel nodes after neoadjuvant therapy (ADARNAT trial). Front Oncol. 2023;13:1184021. doi:10.3389/fonc.2023.1184021
  • Hara Y, Otsubo R, Shinohara S, et al. Lymphedema after axillary lymph node dissection in breast cancer: prevalence and risk factors—a single-center retrospective study. Lymphat Res Biol. 2022;20(6):600–606. doi:10.1089/lrb.2021.0033
  • Wibisana IG. Sentinel lymph node biopsy for breast cancer using methylene blue: a new anatomical landmark involving intercostobrachial and medial pectoral nodes. Medical J Indones. 2020;29(3):298–304. doi:10.13181/mji.oa.204008
  • Wariss BR, Costa RM, Pereira AC, Koifman RJ, Bergmann A. Axillary web syndrome is not a risk factor for lymphoedema after 10 years of follow-up. Support Care Cancer. 2017;25:465–470. doi:10.1007/s00520-016-3424-7
  • Haigh PI, Hansen NM, Qi K, Giuliano AE. Biopsy method and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer. Ann Surg Oncol. 2000;7:21–27. doi:10.1007/s10434-000-0021-1
  • Suami H, Pan WR, Taylor GI. Historical review of breast lymphatic studies. Clin Anat. 2009;22(5):531–536. doi:10.1002/ca.20812
  • Estourgie SH, Valdes Olmos RA, Nieweg OE, Hoefnagel CA, Rutgers EJ, Kroon BB. Excision biopsy of breast lesions changes the pattern of lymphatic drainage. Br J Surg. 2007;94(9):1088–1091. doi:10.1002/bjs.5763
  • Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer—a multicenter validation study. N Engl J Med. 1998;339(14):941–946. doi:10.1056/NEJM199810013391401
  • Feldman SM, Krag DN, McNally RK, et al. Limitation in gamma probe localization of the sentinel node in breast cancer patients with large excisional biopsy. J Am Coll Surg. 1999;188(3):248–254. doi:10.1016/s1072-7515(98)00306-8